The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Georgia Tech Research Corporation for development and production of B-cells for antibodies. Their laboratory is the only known one with proven success at generating antibodies to polysaccarides. Please see attached sole source letter for more information.

This contract action is for (supplies/services) in which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement.

This notice of intent is not a request for competitive quotations; however, all responses received within four (4) days of the issuance of this notice will be reviewed. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Any response should be emailed to the contract specialist at [email protected] by 10:00am EST Friday, June 28, 2019.

Bid Protests Not Available